Article

ACR 2011: Dr. Joseph Kim's Conference Highlights [VIDEO]

Conference|American College of Rheumatology

In this video, Dr. Joseph Kim speaks about his experience at the American College of Rheumatology Annual Conference in Chicago, IL.

Joseph Kim, MD, talks about his time at the Annual Scientific Meeting of the American College of Rheumatology, reviewing sessions he attended and giving an overview of his experience at the conference.

The activity is not sanctioned by, nor a part of, the American College of Rheumatology.

Related Videos
Shawn Kwatra, MD: Making the Connection Between Prurigo Nodularis, Atopic Dermatitis, and Itch
Will Herrington, MBBS, MD, MA: Empagliflozin Follow-up Data Informs Clinical Care for CKD
Jennifer Lai Yee, MD, PhD, MPH: Honing in on Sparsentan’s Benefit in Genetic FSGS
Highlighting Recent Therapies for Dermatologists, with James Del Rosso, DO
Ladan Zand, MD: Obinutuzumab Promising Option for Refractory, Primary FSGS
Rahul N. Khurana, MD: Phase 1 Results on Vamikibart for Uveitic Macular Edema | Image Credit: Northern California Retina Vitreous Associates
Sunir J. Garg, MD: | Image Credit: Wills Eye Hospital
James Del Rosso, DO: Discussing What’s New in the Medicine Chest for Dermatologists
What to Look Forward To at the Fall Clinical Dermatology Conference, with Raj Chovatiya, MD, PhD
Related Content
Despite Guidelines, Systemic Corticosteroids Remain Widely Prescribed for Atopic Dermatitis
October 26th 2024

Despite Guidelines, Systemic Corticosteroids Remain Widely Prescribed for Atopic Dermatitis

Tim Smith
default thumbnail for Don't Miss a Beat podcast.
September 2nd 2024

Don't Miss a Beat: Finerenone's Role in Heart Failure from ESC Congress Data

Muthiah Vaduganathan, MD, MPH Stephen Greene, MD
Hiddo Heerspink, PharmD, PhD | Credit: George Institute for Global Health
October 25th 2024

Semaglutide Shows Promise, Reduces UACR in Nondiabetic Kidney Disease

Patrick Campbell
Default thumbnail for Diabetes Dialogue, featuring podcast logo and headshots of hosts.
August 21st 2024

Diabetes Dialogue: Sotagliflozin for T1D and Other ADCES 2024 Highlights

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
Will Herrington, MA, MBBS, MD, FRCP, FERA, Professor of Trials and Epidemiology of Kidney Disease, Renal Studies Group, Nuffield Department of Population Health, and practicing Honorary Consultant Nephrologist, Oxford Kidney Unit, Oxford University
October 25th 2024

Empagliflozin Benefits on Kidney Disease Progression, Death Continue for 1 Year Post-Discontinuation

Victoria Johnson
Finnian McCausland, MBBCh | Credit: Mass General Brigham
October 25th 2024

Finerenone Use Reduces UACR, New-Onset Macroalbuminuria in Heart Failure Patients

Patrick Campbell
© 2024 MJH Life Sciences

All rights reserved.